Science Explorer Back to mapMap

Most cited papers from California Retina Consultants

What are the most cited papers from California Retina Consultants?

The most cited paper from California Retina Consultants is "Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration" (Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al., 2006), with 1,141 citations. Next come "Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis" (868) and "International Classification of Retinopathy of Prematurity, Third Edition" (822).

Showing 50 of 59 papers. Every paper with more than 108 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology 4 Feb 2006 1,141
2 Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis Wolfgang Hueber et al. · Science Translational Medicine 6 Oct 2010 868
3 International Classification of Retinopathy of Prematurity, Third Edition Michael F. Chiang et al. · Ophthalmology Open access 8 Jul 2021 822
4 Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy Robert L. Avery, Joel A. Pearlman, Dante J. Pieramici et al. · Ophthalmology Oct 2006 803
5 Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA Open access 13 Nov 2015 779
6 Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Michael J. Elman, Neil M. Bressler, Haijing Qin et al. · Ophthalmology Open access Apr 2011 573
7 Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease Yosef Koronyo, David Biggs, Ernesto Barrón et al. · JCI Insight Open access 16 Aug 2017 537
8 Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Quan Dong Nguyen et al. · Ophthalmology 20 Sep 2010 533
9 Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Jeffrey S. Heier et al. · The Lancet Open access263 authors Oct 2023 509
10 Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy J. Fernando Arévalo, Maurício Maia, Harry W. Flynn et al. · British Journal of Ophthalmology 26 Oct 2007 410
11 A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration Amir H. Kashani, JANE S. LEBKOWSKI, Firas M. Rahhal et al. · Science Translational Medicine 4 Apr 2018 396
12 Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD Robert L. Avery, ALESSANDRO A. CASTELLARIN, Nathan C. Steinle et al. · British Journal of Ophthalmology Open access 7 Jul 2014 382
13 SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB Robert L. Avery, ALESSANDRO A. CASTELLARIN, Nathan C. Steinle et al. · Retina Open access 19 Jan 2017 355
14 Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab Peter A. Campochiaro, Raafay Sophie, Joel A. Pearlman et al. · Ophthalmology Open access 7 Oct 2013 354
15 ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) Jonathan Shahar, Robert L. Avery, Gad Heilweil et al. · Retina 27 Feb 2006 354
16 REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT Robert L. Avery · Retina 27 Feb 2006 344
17 Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration Gui‐Shuang Ying, Jiayan Huang, Maureen G. Maguire et al. · Ophthalmology Open access 6 Oct 2012 314
18 Modified Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema Carol M. Lee, R. Joseph Olk · Ophthalmology Oct 1991 312
19 Visual Results after Surgical Removal of Subfoveal Choroidal Neovascular Membranes Matthew A. M. Thomas, John D. Dickinson, Nancy S. Melberg et al. · Ophthalmology Aug 1994 307
20 Punctate Inner Choroidopathy Robert C. Watzke, Andrew J. Packer, James C. Folk et al. · American Journal of Ophthalmology Nov 1984 285
21 INTRAVITREAL INJECTION TECHNIQUE AND MONITORING Robert L. Avery, Sophie J. Bakri, Mark Scott Blumenkranz et al. · Retina Dec 2014 272
22 Surgical Management of Subfoveal Choroidal Neovascularization Matthew A. Thomas, M. Gilbert Grand, David F. Williams et al. · Ophthalmology Jun 1992 260
23 Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement Adam S. Hassan, Mark W. Johnson, Todd E. Schneiderman et al. · Ophthalmology Oct 1999 260
24 INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION Melvin Rabena, Dante J. Pieramici, ALESSANDRO A. CASTELLARIN et al. · Retina 30 Mar 2007 245
25 Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide screening program Paisan Ruamviboonsuk et al. · npj Digital Medicine Open access 10 Apr 2019 234
26 Nuclear Sclerotic Cataract after Vitrectomy in Patients Younger than 50 Years of Age Nancy S. Melberg, M.A. Thomas · Ophthalmology Oct 1995 226
27 Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema Robert L. Avery, Gabriel M. Gordon · JAMA Ophthalmology Open access 29 Oct 2015 220
28 Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment Susan B. Bressler, Allison R. Ayala, Neil M. Bressler et al. · JAMA Ophthalmology Open access 11 Jan 2016 217
29 The Expanded Spectrum of Focal Choroidal Excavation Ron Margolis · Archives of Ophthalmology 14 Jun 2011 216
30 Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications Zongzhong Tong et al. · Proceedings of the National Academy of Sciences Open access 5 May 2008 209
31 MACULAR HOLE SURGERY WITHOUT FACE-DOWN POSITIONING Paul E. Tornambe, LON S. POLINER, KURT GROTE · Retina May 1997 190
32 Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience Anne L. Peters, Antonio P. Legorreta, R. Clifford Ossorio et al. · Diabetes Care Jun 1996 188
33 Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Nancy M. Holekamp, Peter A. Campochiaro, MARGARET A. CHANG et al. · Ophthalmology Open access 29 Sep 2021 185
34 Surgical Removal of Subfoveal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome M.A. Thomas, Henry J. Kaplan · American Journal of Ophthalmology 1991 183
35 Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab André J. Witkin, Paul Hahn, Timothy G. Murray et al. · Journal of VitreoRetinal Diseases Open access Jul 2020 182
36 Vitrectomy for Premacular Fibroplasia Samuel R. Pesin, R. Joseph Olk, M. Gilbert Grand et al. · Ophthalmology Jul 1991 182
37 The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results Arshad M. Khanani, Aamir A Aziz, Hannah Khan et al. · Eye Open access 12 May 2023 181
38 Modified Grid Argon (Blue-Green) Laser Photocoagulation for Diffuse Diabetic Macular Edema R. Joseph Olk · Ophthalmology Jul 1986 181
39 KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema David M. Brown, Andrés Emanuelli, Francesco Bandello et al. · American Journal of Ophthalmology Open access 14 Jan 2022 172
40 Change in Diabetic Retinopathy Through 2 Years Susan B. Bressler, Danni Liu, Adam R. Glassman et al. · JAMA Ophthalmology Open access 27 Apr 2017 164
41 Sequential Unmasking: A Means of Minimizing Observer Effects in Forensic DNA Interpretation Dan E. Krane, Simon Ford, Jason R. Gilder et al. · Journal of Forensic Sciences Open access Jul 2008 161
42 Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration Glenn J. Jaffe, Thomas A. Ciulla, Antonio Pasquale Ciardella et al. · Ophthalmology Open access 28 Oct 2016 150
43 Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments Chandrakumar Balaratnasingam, Lawrence A. Yannuzzi, Christine A. Curcio et al. · Investigative Ophthalmology & Visual Science Open access 19 Oct 2016 148
44 Vitrectomy for Prevention of Macular Holes Serge de Bustros et al. · Ophthalmology Open access Jun 1994 134
45 Surgical Management of Submacular Hemorrhage Hector E. Ibanez · Archives of Ophthalmology 1995 134
46 Idiopathic Retinitis, Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Michael Samuel, Robert A. Equi, Tom Chang et al. · Ophthalmology Aug 2007 134
47 ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE) MONICA GIGANTI, Paul M. Beer, Nicole Lemanski et al. · Retina 2010 132
48 Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study Peter A. Campochiaro, Robert L. Avery, David M. Brown et al. · The Lancet 27 Mar 2024 129
49 Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration Philip J. Rosenfeld, Pravin U. Dugel, Frank Gerhard Holz et al. · Ophthalmology Open access 30 Apr 2018 124
50 INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR REFRACTORY PSEUDOPHAKIC CYSTOID MACULAR EDEMA John O. Mason, Michael A. Albert, Rachel S. Vail · Retina 27 Feb 2006 120

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.